Conditions Atlas
174 medical conditions where hirudotherapy has been applied — from FDA-cleared microsurgical flap salvage to Tier C investigational uses. Every entry tier-classified, evidence-graded, and linked to primary literature.
174
Total conditions
3
Tier A FDA-cleared
7
Tier B RCT-supported
164
Tier C investigational
cardiovascular
4 conditions
Essential Hypertension (Adjunctive)
C · InvestigationalInvestigational adjunctive use with only non-randomized clinical reports identified; proposed mechanisms are blood-volume removal and hirudin effects on vessels; not a substitute for pharmacotherapy.
Atrial Fibrillation (Adjunctive Investigational)
C · InvestigationalHighly investigational adjunct for paroxysmal atrial fibrillation; no controlled trials; conventional anticoagulation and rate/rhythm control remain primary.
Congestive Heart Failure (Compensated, Investigational Adjunct)
C · InvestigationalInvestigational adjunct in compensated NYHA II heart failure; only small open-label or uncontrolled studies were identified, mostly in Russian-language sources; guideline-directed medical therapy remains primary.
Peripheral Artery Disease (Claudication, Investigational)
C · InvestigationalHighly investigational adjunct for intermittent claudication; ABI must be assessed first; critical limb ischemia is an absolute contraindication.
dermatological
36 conditions
Livedo Reticularis
C · InvestigationalInvestigational use for primary livedo reticularis; no clinical study was identified. Secondary causes (lupus, APLAS) require rheumatology referral.
Lipodermatosclerosis
C · InvestigationalInvestigational use for chronic lipodermatosclerosis; no study in this condition was identified, only small series in venous ulcer and varicose disease.
Insulin Injection Lipohypertrophy
C · InvestigationalInvestigational use for insulin injection-related lipohypertrophy nodules; no clinical study of leech therapy for them was identified.
Androgenic Alopecia
C · InvestigationalInvestigational use for androgenic alopecia; the only clinical report is a single-patient Ayurvedic case study, with no controlled trial.
Rosacea (Erythematotelangiectatic)
C · InvestigationalInvestigational use for erythematotelangiectatic rosacea; no clinical study of leech therapy was identified.
Plaque Psoriasis (Localized)
C · InvestigationalInvestigational adjunct, not a primary treatment; a few small, mostly uncontrolled studies report lower PASI scores.
Atopic Eczema (Localized Refractory)
C · InvestigationalInvestigational use for localized refractory eczema; evidence is limited to a few small studies without placebo or standard-care controls.
Keloid and Hypertrophic Scarring
C · InvestigationalInvestigational use for keloid and hypertrophic scars; evidence is limited to one small uncontrolled series and two conflicting single-patient reports.
Chronic Recurrent Cellulitis
C · InvestigationalInvestigational use for chronic recurrent (non-acute) cellulitis with underlying lymphedema or venous insufficiency.
Hidradenitis Suppurativa (Hurley Stage I-II)
C · InvestigationalNot recommended: the only published report of leech therapy in hidradenitis suppurativa describes a harmful outcome.
Severe Inflammatory Acne Vulgaris
C · InvestigationalHighly investigational use for severe nodulocystic acne refractory to isotretinoin; small Ayurvedic studies only, none in refractory disease, and scarring risk concerns.
Hypertrophic Scars
C · InvestigationalInvestigational adjunct for hypertrophic scars (within the original wound), distinct from keloid; evidence is one small uncontrolled Russian series.
Cutaneous Lichen Planus (Localized)
C · InvestigationalInvestigational use for localized cutaneous lichen planus refractory to topical corticosteroid; very limited case-report evidence.
Small Localized Subcutaneous Lipoma
C · InvestigationalHighly investigational use for small subcutaneous lipoma (<3 cm) with cosmetic concern; surgical excision remains standard; very limited data.
Plantar Warts (Verruca Plantaris, Refractory)
C · InvestigationalHighly investigational use for refractory plantar warts (HPV-mediated) after cryotherapy and salicylic acid failure; very limited anecdotal evidence.
Small Localized Skin Abscess (Post-Drainage)
C · InvestigationalInvestigational adjunct after drainage of small localized skin abscess; not for undrained abscesses; evidence limited to reports, mostly in related infections.
Vitiligo (Investigational)
C · InvestigationalHighly investigational adjunct for limited stable vitiligo; case reports only; topical calcineurin inhibitors, narrow-band UVB, and ruxolitinib cream remain primary.
Alopecia Areata (Investigational Adjunct)
C · InvestigationalInvestigational adjunct for stable patchy alopecia areata; case reports only; intralesional corticosteroids and JAK inhibitors (baricitinib, ritlecitinib) remain primary.
Melasma (Investigational Adjunct)
C · InvestigationalHighly investigational adjunct for refractory melasma; uncontrolled reports only; sun protection, hydroquinone, tretinoin, tranexamic acid, and chemical peels remain primary.
Post-Inflammatory Hyperpigmentation (Investigational)
C · InvestigationalHighly investigational adjunct for refractory PIH; no clinical study found; sun protection, topical hypopigmenting agents, and chemical peels remain primary.
Lichen Sclerosus (Investigational Adjunct)
C · InvestigationalHighly investigational adjunct for refractory lichen sclerosus; one small uncontrolled series (vulvar), no RCT; clobetasol remains standard of care.
Granuloma Annulare (Investigational Adjunct)
C · InvestigationalHighly investigational adjunct for localized granuloma annulare; no clinical study found; many lesions resolve spontaneously within 1-2 years.
Localized Scleroderma / Morphea (Investigational Adjunct)
C · InvestigationalHighly investigational adjunct for stable plaque morphea; no RCT evidence; UVA1 phototherapy and methotrexate remain primary for active disease.
Cutis Marmorata Telangiectatica Congenita (Investigational)
C · InvestigationalHighly investigational; supportive care and monitoring of associated anomalies remain primary; no clinical report of leech therapy for CMTC was identified.
Chronic Radiation Dermatitis (Investigational)
C · InvestigationalHighly investigational adjunct for chronic radiation dermatitis after oncology completion; no clinical report of leech therapy was identified; standard skin care and dermatology referral remain primary.
Shingles (Acute Herpes Zoster)
C · InvestigationalNo controlled study of leech therapy for acute shingles exists; antiviral treatment started early is standard care, and leeches must never be placed on or near the rash.
Nail Psoriasis (Investigational Adjunct)
C · InvestigationalInvestigational adjunct for nail psoriasis; topical corticosteroids, intralesional steroid, and (for severe disease) systemic biologics remain evidence-based.
Prurigo Nodularis (Investigational Adjunct)
C · InvestigationalInvestigational adjunct for refractory prurigo nodularis; potent topical/intralesional steroids, gabapentinoids, and dupilumab (FDA-approved 2022) remain evidence-based.
Chronic Pruritus of Unknown Origin (Investigational Adjunct)
C · InvestigationalInvestigational adjunct for chronic pruritus of unknown origin after systemic workup; antihistamines, gabapentinoids, and (for select cases) systemic immunomodulators remain evidence-based.
Behcet Disease Orogenital Mucocutaneous Manifestations (Investigational Adjunct)
C · InvestigationalInvestigational adjunct for cutaneous manifestations of Behcet disease; colchicine, apremilast, azathioprine, TNF inhibitors, and rheumatology supervision remain evidence-based.
Chronic Recurrent Chilblains (Pernio, Investigational Adjunct)
C · InvestigationalInvestigational adjunct for chronic recurrent chilblains; cold avoidance, smoking cessation, calcium channel blockers (nifedipine), and topical corticosteroids remain evidence-based.
Chronic Idiopathic Urticaria (Investigational Adjunct)
C · InvestigationalInvestigational adjunct for chronic spontaneous urticaria refractory to high-dose H1 antihistamines; omalizumab, cyclosporine, and step-up guideline-directed therapy remain evidence-based.
Recurrent Erythema Nodosum (Investigational Adjunct)
C · InvestigationalInvestigational adjunct for recurrent idiopathic erythema nodosum; identification and treatment of underlying cause, NSAIDs, potassium iodide, and (refractory) colchicine remain evidence-based.
Hailey-Hailey Disease (Benign Familial Pemphigus, Investigational Adjunct)
C · InvestigationalInvestigational adjunct for refractory Hailey-Hailey disease; topical corticosteroids, topical antibiotics, topical calcineurin inhibitors, oral antibiotics, and (refractory) botulinum toxin or surgical interventions remain evidence-based.
Lichen Simplex Chronicus (Investigational Adjunct)
C · InvestigationalInvestigational adjunct for lichen simplex chronicus; breaking the itch-scratch cycle with potent topical corticosteroids, occlusion, topical calcineurin inhibitors, and treatment of underlying pruritus etiology remain evidence-based.
Necrobiosis Lipoidica (Investigational Adjunct)
C · InvestigationalInvestigational adjunct for stable non-ulcerated necrobiosis lipoidica; no clinical leech study was identified; topical corticosteroids remain first-line.
ent
15 conditions
Chronic Rhinosinusitis
B · RCT-supportedInvestigational use for chronic rhinosinusitis; no clinical study of leech therapy for this condition was identified, and the rationale is mechanistic.
Subjective Tinnitus
C · InvestigationalInvestigational for tinnitus; small non-randomized studies, mostly Russian, report less ear noise, and no study using the Tinnitus Handicap Inventory was identified.
Ménière's Disease (Adjunctive)
C · InvestigationalInvestigational adjunct for Ménière's disease with no clinical study identified; standard management (diet, betahistine, intratympanic therapy) remains primary.
Pulsatile Tinnitus (Vascular-Origin Subtype)
C · InvestigationalInvestigational use for pulsatile vascular-origin tinnitus distinct from subjective tinnitus; no clinical study of leech therapy for this subtype was identified.
Peripheral Vertigo (BPPV-Refractory / Vestibular Neuritis Recovery)
C · InvestigationalInvestigational adjunct for peripheral vertigo persisting after Epley maneuvers or during prolonged vestibular neuritis recovery; no study specific to these conditions was identified.
Chronic Tonsillitis (Investigational Cervical Adjunct)
C · InvestigationalHighly investigational cervical adjunct for chronic tonsillitis; no clinical study found; tonsillectomy and antibiotics remain primary; cervical leech placement carries carotid-proximity risk.
Recurrent Otitis Media in Adults (Investigational)
C · InvestigationalHighly investigational adjunct for adult recurrent otitis media; no condition-specific study found; antibiotics and ENT evaluation remain primary.
Vasomotor Rhinitis (Investigational)
C · InvestigationalInvestigational adjunct for nonallergic vasomotor rhinitis; one uncontrolled Russian series only; intranasal ipratropium and antihistamine remain primary.
Chronic Laryngitis (Investigational Cervical Adjunct)
C · InvestigationalHighly investigational cervical adjunct for chronic laryngitis; no clinical study found; ENT evaluation for underlying causes remains primary.
Chronic Glossitis (Investigational Adjunct)
C · InvestigationalHighly investigational adjunct for chronic glossitis; no study in glossitis found; treating nutritional, infectious or allergic causes remains primary.
Sensorineural Hearing Loss (chronic) and Sudden Hearing Loss
C · InvestigationalNo randomized trial was found; a few small reports without described randomization or blinding mention less ear noise and some hearing gain in chronic loss. Sudden hearing loss is an emergency: urgent ENT care comes first, and leeches must never delay it.
Chronic Otitis Externa (Investigational Adjunct)
C · InvestigationalInvestigational adjunct for refractory chronic otitis externa; topical antimicrobials, aural toilet, and predisposing-factor management remain evidence-based.
Sicca Syndrome (Investigational Adjunct)
C · InvestigationalInvestigational adjunct for sicca (dry eye and dry mouth) symptoms; ophthalmologic lubricants, salivary stimulants (pilocarpine, cevimeline), and rheumatology workup remain evidence-based.
Burning Mouth Syndrome (Investigational Adjunct)
C · InvestigationalInvestigational adjunct for primary burning mouth syndrome; clonazepam (topical or systemic), alpha-lipoic acid, low-dose tricyclics, and cognitive behavioral therapy remain evidence-based.
Chronic Eustachian Tube Dysfunction (Investigational Adjunct)
C · InvestigationalInvestigational adjunct for chronic Eustachian tube dysfunction; nasal corticosteroids, antihistamines for allergic etiology, Valsalva maneuvers, and (refractory) balloon Eustachian tuboplasty remain evidence-based.
gastrointestinal
9 conditions
Hemorrhoids (Grade II-III, Symptomatic)
C · InvestigationalInvestigational use for symptomatic relief of grade II-III internal/external hemorrhoidal disease; does not address anatomic prolapse.
Chronic Anal Fissure (>8 Weeks)
C · InvestigationalInvestigational idea for chronic anal fissure refractory to medical therapy; no clinical study identified; sphincterotomy remains the gold standard.
Non-Alcoholic Fatty Liver Disease (Investigational Adjunct)
C · InvestigationalInvestigational adjunct in NAFLD/MASLD; no human clinical study identified; weight loss, dietary modification, and resmetirom remain primary.
Hepatic Portal Congestion (Non-Cirrhotic, Investigational)
C · InvestigationalHighly investigational adjunct for non-cirrhotic hepatic congestion; uncontrolled Russian series only; cirrhosis and portal hypertension are absolute exclusions.
Chronic Pancreatitis (Investigational Pain Adjunct)
C · InvestigationalHighly investigational adjunct for chronic pancreatitis pain refractory to conventional therapy; no clinical study identified; pancreatic enzyme replacement and pain medicine remain primary.
Ulcerative Proctitis (Investigational Adjunct)
C · InvestigationalHighly investigational adjunct for distal ulcerative proctitis; no clinical study found; topical 5-ASA and corticosteroids remain primary.
Symptomatic Gilbert Syndrome (Investigational Adjunct)
C · InvestigationalInvestigational adjunct for symptomatic Gilbert syndrome; reassurance, trigger avoidance (fasting, dehydration), and acknowledgment of benign genetic etiology remain primary; no FDA-approved therapy.
Functional Dyspepsia (Investigational Adjunct)
C · InvestigationalInvestigational adjunct for functional dyspepsia (Rome IV criteria); H. pylori eradication when positive, proton pump inhibitors, prokinetics, and tricyclic antidepressants remain evidence-based.
Irritable Bowel Syndrome, Pain-Predominant (Investigational Adjunct)
C · InvestigationalInvestigational adjunct for pain-predominant IBS refractory to dietary and pharmacologic therapy; low-FODMAP diet, antispasmodics, low-dose tricyclic antidepressants, and cognitive behavioral therapy or gut-directed hypnotherapy remain evidence-based.
gynecologic
11 conditions
Lactational Mastitis (Non-Suppurative)
C · InvestigationalInvestigational adjunctive use proposed for non-suppurative lactational mastitis; no clinical study of leech therapy was identified.
Endometriosis-Related Pelvic Pain
C · InvestigationalInvestigational adjunctive use for chronic endometriosis-related pelvic pain; very limited evidence. Not a substitute for hormonal or surgical management.
Primary Dysmenorrhea
C · InvestigationalInvestigational for primary dysmenorrhea; one small randomized trial of leeches plus cupping versus an oral contraceptive pill reported lower pain scores.
Chronic Pelvic Pain Syndrome (Non-Specific)
C · InvestigationalInvestigational for non-specific chronic pelvic pain; the only clinical report located is an uncontrolled 60-woman series in which leeches were one part of multimodal care.
Premenstrual Syndrome (Investigational)
C · InvestigationalInvestigational adjunct for moderate PMS refractory to conventional therapy; no clinical study identified; SSRI and combined hormonal contraception remain primary.
Polycystic Ovary Syndrome (Investigational Adjunct)
C · InvestigationalInvestigational adjunct in PCOS; no clinical study identified; lifestyle modification, combined hormonal contraception, metformin, and ovulation induction remain primary.
Vulvodynia (Investigational)
C · InvestigationalHighly investigational adjunct for chronic vulvodynia refractory to conventional therapy; no clinical study identified; pelvic floor PT, topical therapy, and TCAs remain primary.
Cyclical Mastalgia (Investigational Adjunct)
C · InvestigationalInvestigational adjunct for severe cyclical mastalgia refractory to conventional therapy; no clinical study identified; reassurance, lifestyle modification, and selective danazol/tamoxifen remain primary.
Pelvic Congestion Syndrome (Investigational Adjunct)
C · InvestigationalInvestigational adjunct for pelvic congestion syndrome; medical therapy (progestins, GnRH analogs) and ovarian vein embolization remain evidence-based.
Endometrioma (Palliative Investigational Adjunct)
C · InvestigationalPalliative investigational adjunct for endometrioma-related chronic pelvic pain in patients declining or unable to undergo surgical/hormonal management.
Adenomyosis (Investigational Palliative Adjunct)
C · InvestigationalInvestigational palliative adjunct for adenomyosis-related dysmenorrhea and pelvic pain; hormonal therapy (LNG-IUD, dienogest, GnRH antagonists) and (definitively) hysterectomy remain evidence-based.
musculoskeletal
33 conditions
Knee Osteoarthritis
B · RCT-supportedOff-label use; several small RCTs in knee OA report pain and function improvement with leeches versus NSAID gel, sham leech or TENS, though results against sham and TENS are mixed, and a 2022 trial against physiotherapy found no therapeutic effect.
Rheumatoid Arthritis
C · InvestigationalNo published clinical study of leech therapy in rheumatoid arthritis was identified; early disease-modifying treatment remains the standard, and leeches must never replace or delay it.
Thumb Carpometacarpal (CMC-1) Osteoarthritis
B · RCT-supportedOff-label use with one small RCT (Michalsen 2008, 32 women) in which single-session leech therapy reduced pain and improved hand function more than topical diclofenac for about 2 months.
Lateral Epicondylitis (Tennis Elbow)
B · RCT-supportedOff-label use with one small RCT (Bäcker 2011, n=40) in which a single leech session reduced pain more than topical diclofenac at day 7; the pain difference was no longer significant at day 45.
Plantar Fasciitis
C · InvestigationalInvestigational use; no clinical study of leech therapy for plantar fasciitis was identified, and the rationale is mechanistic only.
Chronic Low Back Pain (nonspecific)
B · RCT-supportedOne small, unblinded randomized trial (Hohmann 2018, n=44): back pain was lower 4 weeks after leech therapy than after exercise therapy; follow-up 8 weeks.
Fibromyalgia
C · InvestigationalInvestigational use only: no controlled clinical study of leech therapy for fibromyalgia was identified, and it is not a primary treatment.
Acute Gout Flare
C · InvestigationalInvestigational use for acute monoarticular gout when NSAIDs and colchicine are contraindicated; evidence limited to a few small Ayurvedic pilot studies.
Mid-Substance Achilles Tendinopathy
C · InvestigationalInvestigational use for chronic mid-substance Achilles tendinopathy; evidence limited to isolated single-patient reports.
Rotator Cuff Tendinopathy
C · InvestigationalInvestigational use for non-surgical rotator cuff tendinopathy and chronic shoulder impingement; evidence limited to isolated case reports.
Trigger Finger (Stenosing Tenosynovitis)
C · InvestigationalInvestigational use for stenosing tenosynovitis of the digital flexor pulleys; evidence limited to a single Ayurvedic case report.
Dupuytren's Contracture (Early Stage)
C · InvestigationalInvestigational use in Dupuytren's disease; evidence limited to one uncontrolled Russian-language report in patients with contracture.
Plantar Fibromatosis (Ledderhose Disease)
C · InvestigationalInvestigational use for plantar fascia nodules in early Ledderhose disease; no clinical study of leech therapy for this condition was identified.
Adhesive Capsulitis (Frozen Shoulder)
C · InvestigationalInvestigational adjunct in frozen shoulder; the only clinical reports identified are two single-patient case reports, with no controlled data.
Insertional Achilles Tendinopathy
C · InvestigationalInvestigational use for insertional Achilles tendinopathy; no clinical study of leech therapy for it was identified.
De Quervain's Tenosynovitis
C · InvestigationalInvestigational use for stenosing tenosynovitis of the first dorsal extensor compartment; no clinical study of leech therapy for it was identified.
Calcaneal Heel Spur (Symptomatic)
C · InvestigationalInvestigational use for symptomatic plantar calcaneal spur; distinguished from plantar fasciitis by radiographic spur with localized pain.
Subacromial Bursitis (Chronic)
C · InvestigationalInvestigational use for chronic subacromial bursitis (not acute septic bursitis); no clinical study of leech therapy was identified.
Costochondritis (Chronic)
C · InvestigationalInvestigational use for chronic costochondritis after cardiac causes are excluded; no clinical study of leech therapy was identified.
Sacroiliac Joint Dysfunction
C · InvestigationalInvestigational use for SI joint mechanical pain with positive provocation tests; no clinical study of leech therapy was identified.
Pubic Symphysis Dysfunction (Non-Pregnancy)
C · InvestigationalInvestigational use for non-pregnancy pubic symphysis dysfunction, including osteitis pubis; no clinical study of leech therapy was identified.
Coccydynia (Chronic)
C · InvestigationalInvestigational use for chronic coccyx pain after fall, childbirth, or idiopathic onset; no clinical study of leech therapy was identified.
Piriformis Syndrome (Isolated, FAIR-Positive)
C · InvestigationalInvestigational use for isolated piriformis syndrome (positive FAIR test, lumbar pathology excluded); no clinical study of leech therapy was identified.
Myofascial Pain Syndrome (Investigational Adjunct)
C · InvestigationalInvestigational adjunct for chronic myofascial trigger-point pain; one small randomized trial (n=66) and Russian clinical series only; dry needling, manual therapy, and exercise remain primary.
Patellar Tendinopathy (Jumper's Knee, Investigational)
C · InvestigationalInvestigational adjunct for chronic patellar tendinopathy (Blazina stage II-III); eccentric loading and heavy slow resistance training remain primary.
Proximal Hamstring Tendinopathy (Investigational)
C · InvestigationalInvestigational adjunct for chronic proximal hamstring tendinopathy at ischial origin; eccentric loading and load management remain primary.
Greater Trochanteric Pain Syndrome (Investigational)
C · InvestigationalInvestigational adjunct for chronic greater trochanteric pain syndrome (gluteal tendinopathy); load management and hip-abductor strengthening remain primary.
Ischial Bursitis (Investigational Adjunct)
C · InvestigationalInvestigational adjunct for refractory ischial (ischiogluteal) bursitis; activity modification, hamstring loading, and selective injection remain primary.
Hip Osteoarthritis (Investigational Adjunct)
C · InvestigationalInvestigational adjunct for symptomatic hip osteoarthritis; weight management, exercise, NSAIDs, and arthroplasty for end-stage disease remain evidence-based.
Temporomandibular Joint Disorder (Investigational Adjunct)
C · InvestigationalInvestigational adjunct for chronic temporomandibular joint disorder; conservative care (education, jaw exercises, occlusal splint, NSAIDs) remains first-line; specialty referral for refractory cases.
Chronic Cervical Myofascial Pain (Investigational Adjunct)
C · InvestigationalInvestigational adjunct for chronic cervical myofascial pain; education, exercise therapy, ergonomic correction, and trigger-point therapy remain primary.
Ankylosing Spondylitis Axial Pain (Investigational Adjunct)
C · InvestigationalInvestigational adjunct for axial pain in ankylosing spondylitis; NSAIDs, biologic DMARDs (TNF and IL-17 inhibitors), and structured exercise remain evidence-based first-line therapy.
Iliotibial Band Syndrome (Investigational Adjunct)
C · InvestigationalInvestigational adjunct for chronic iliotibial band syndrome refractory to standard physical therapy and load-management; activity modification, eccentric hip strengthening, and corticosteroid injection remain evidence-based.
neurological
31 conditions
Cervical Radiculopathy
C · InvestigationalInvestigational use for cervical radiculopathy; no verifiable published trial specific to this indication.
Lumbar Radiculopathy (Sciatica)
C · InvestigationalInvestigational use for lumbar radiculopathy; the closest randomized evidence is in chronic low back pain (Hohmann 2018, n=44), not radicular pain.
Migraine
C · InvestigationalInvestigational use; the only clinical studies found in journal searches are a 7-patient case series and a 26-patient non-randomized pilot (older reports are described in “What the books describe”), and the proposed mechanism is hypothetical.
Tension-Type Headache
C · InvestigationalInvestigational use for chronic tension-type headache; no study for this headache type was identified, and the proposed mechanism (muscle tension, venous congestion) is untested.
Sciatica (Non-Discogenic / Piriformis)
C · InvestigationalInvestigational use for non-discogenic sciatica including piriformis syndrome; no controlled trial, only an old unquantified Russian case series.
Bell's Palsy (Acute Idiopathic Facial Paralysis)
C · InvestigationalInvestigational adjunct in acute idiopathic facial nerve palsy; no controlled trial identified, only uncontrolled series and single-case reports.
Trigeminal Neuralgia (Classical / Idiopathic)
C · InvestigationalInvestigational use for classical trigeminal neuralgia refractory to first-line carbamazepine; only two single-patient case reports were located in journals (see also “What the books describe”).
Lumbosacral Radiculopathy (Non-Discogenic)
C · InvestigationalInvestigational use for lumbosacral radicular pain without disc herniation (foraminal stenosis, facet hypertrophy, lateral recess); no study specific to this subtype was identified.
Carpal Tunnel Syndrome (Mild-Moderate)
C · InvestigationalInvestigational use for mild-to-moderate carpal tunnel syndrome; only one single-patient case report and one randomized-trial protocol without results were identified.
Tarsal Tunnel Syndrome
C · InvestigationalInvestigational use for posterior tibial nerve entrapment at the medial ankle; no clinical study of leech therapy for it was identified.
Cluster Headache (Episodic)
C · InvestigationalHighly investigational use for episodic cluster headache between attack cycles; very limited anecdotal data, not for active attacks.
Cervicogenic Headache
C · InvestigationalInvestigational adjunct for cervicogenic headache referred from upper cervical (C1-C3) joints; no clinical study in diagnosed cases was identified.
Restless Leg Syndrome (Investigational)
C · InvestigationalInvestigational adjunct for primary RLS refractory to dopamine agonists; no clinical study was identified; iron status and conventional therapy should be optimized first.
Post-Stroke Hemiplegia (Investigational Adjunct)
C · InvestigationalInvestigational adjunct to physical/occupational therapy in chronic post-stroke hemiplegia; no RCT support; not for acute stroke care.
Multiple Sclerosis Fatigue (Investigational Adjunct)
C · InvestigationalInvestigational adjunct for MS-related fatigue; no clinical study was identified; disease-modifying therapy and modafinil/amantadine remain primary.
Parkinson's Disease Rigidity (Investigational Adjunct)
C · InvestigationalInvestigational adjunct for muscular rigidity in idiopathic Parkinson's disease; no clinical study identified; levodopa and physiotherapy remain primary.
Chronic Fatigue Syndrome / ME (Investigational)
C · InvestigationalInvestigational adjunct for myalgic encephalomyelitis/chronic fatigue syndrome; no clinical study identified; conventional pacing and symptom management remain primary.
Complex Regional Pain Syndrome (Type I, Investigational)
C · InvestigationalHighly investigational adjunct for CRPS Type I; one case report and no controlled study identified; multidisciplinary pain management and physiotherapy remain primary.
Phantom Limb Pain (Investigational)
C · InvestigationalHighly investigational adjunct for chronic phantom limb pain; no clinical study identified; mirror therapy and gabapentinoids remain primary.
Spasticity Post-Spinal Cord Injury (Investigational Adjunct)
C · InvestigationalInvestigational adjunct for muscular spasticity after SCI; no clinical study identified; baclofen (oral or intrathecal) and physiotherapy remain primary.
Vascular Cognitive Impairment (Highly Investigational)
C · InvestigationalHighly investigational; no clinical study of leech therapy with cognitive outcomes was identified; vascular risk-factor management (BP, lipids, antiplatelet, lifestyle) remains primary.
Vestibular Migraine (Investigational Adjunct)
C · InvestigationalInvestigational adjunct for refractory vestibular migraine; migraine prophylaxis (propranolol, topiramate, amitriptyline) and vestibular rehabilitation remain primary.
Idiopathic Intracranial Hypertension (Highly Investigational)
C · InvestigationalHighly investigational. Acetazolamide, weight loss, and (for vision-threatening cases) CSF shunting or optic nerve sheath fenestration remain primary; no clinical study of leech therapy for intracranial pressure was identified.
Ramsay Hunt Syndrome (Investigational Adjunct, Convalescent Phase)
C · InvestigationalInvestigational adjunct for convalescent-phase Ramsay Hunt syndrome residual facial weakness; antiviral plus corticosteroid started within 72 hours of onset remains evidence-based.
Post-Herpetic Neuralgia (Investigational Adjunct)
C · InvestigationalInvestigational adjunct for chronic post-herpetic neuralgia; gabapentinoids, tricyclics, and topical lidocaine/capsaicin remain evidence-based; herpes zoster vaccine prevents new cases.
Diabetic Peripheral Neuropathy (Investigational Adjunct)
C · InvestigationalInvestigational adjunct for symptomatic diabetic peripheral neuropathy; glycemic control, foot care, and pharmacotherapy (duloxetine, pregabalin, gabapentin) remain evidence-based.
Cubital Tunnel Syndrome (Investigational Adjunct)
C · InvestigationalInvestigational adjunct for mild cubital tunnel syndrome; elbow extension splinting and ergonomic modification remain first-line; surgical decompression for moderate-severe cases.
Thoracic Outlet Syndrome (Investigational Adjunct)
C · InvestigationalInvestigational adjunct for neurogenic thoracic outlet syndrome; postural correction and scalene rehabilitation remain first-line; surgical decompression for refractory or vascular subtypes.
Meralgia Paresthetica (Investigational Adjunct)
C · InvestigationalInvestigational adjunct for meralgia paresthetica; weight loss, loosening of constrictive clothing, and selective nerve block remain first-line.
Medication-Overuse Headache (Investigational Adjunct)
C · InvestigationalInvestigational adjunct during withdrawal phase of medication-overuse headache; supervised medication discontinuation and preventive therapy initiation remain the foundation.
Cervical Spondylotic Myelopathy Pain (Investigational Adjunct)
C · InvestigationalInvestigational adjunct for paraspinal pain in mild cervical spondylotic myelopathy; surgical decompression remains evidence-based when myelopathic signs progress; conservative management for mild non-progressive disease.
ophthalmologic
3 conditions
Glaucoma (Adjunctive)
C · InvestigationalInvestigational adjunctive use in primary open-angle glaucoma; weak case-series evidence. Not a substitute for IOP-lowering eye drops or surgery.
Dry Eye Syndrome
C · InvestigationalInvestigational use for dry eye disease; no clinical study of leech therapy was identified, and the proposed meibomian-gland mechanism is hypothetical.
Thyroid Eye Disease (Investigational Periocular Adjunct)
C · InvestigationalHighly investigational periocular adjunct for stable thyroid eye disease; ocular risk is critical; teprotumumab and orbital decompression remain primary.
other
5 conditions
Metabolic Syndrome (Investigational Adjunct)
C · InvestigationalInvestigational adjunct to lifestyle modification in metabolic syndrome; no clinical study in metabolic syndrome identified; weight loss, dietary modification, and pharmacotherapy remain primary.
Hashimoto's Thyroiditis (Investigational Cervical Adjunct)
C · InvestigationalHighly investigational adjunct in stable Hashimoto's thyroiditis; small uncontrolled series only; levothyroxine replacement remains primary.
Recurrent Aphthous Stomatitis (Investigational Adjunct)
C · InvestigationalInvestigational adjunct for severe recurrent aphthous stomatitis; topical corticosteroids, chlorhexidine, and (for severe disease) colchicine or systemic immunomodulators remain evidence-based.
Chronic Postsurgical Pain Syndrome (Investigational Adjunct)
C · InvestigationalInvestigational adjunct for chronic postsurgical pain after surgical site healed; multimodal pain management including pharmacotherapy, physical therapy, and (for neuropathic features) interventional pain procedures remain evidence-based.
Dercum Disease (Adiposis Dolorosa, Investigational Adjunct)
C · InvestigationalInvestigational adjunct for painful lipomatous nodules in Dercum disease; analgesics, weight management, surgical excision of selected painful nodules, and lidocaine infusion remain investigational themselves; no FDA-approved disease-modifying therapy.
surgical reconstruction
3 conditions
Venous Congestion in Surgical Flaps
A · FDA-clearedFDA-cleared application: medicinal leech therapy to relieve venous congestion in compromised tissue flaps awaiting vascular ingrowth.
Microsurgical Replantation (Digit / Ear / Scalp)
A · FDA-clearedFDA-cleared application: post-replantation venous decompression in digits, ears, scalp, and partial avulsion injuries.
Breast Reconstruction Flap Salvage
A · FDA-clearedFDA-cleared application: venous decompression of compromised DIEP, TRAM, and latissimus dorsi flaps in post-mastectomy reconstruction.
urogenital
9 conditions
Peyronie's Disease (Stable Phase)
C · InvestigationalInvestigational use for stable-phase Peyronie's disease; evidence limited to one uncontrolled Russian series of 29 patients. Standard treatments (verapamil, collagenase, surgery) remain first-line.
Chronic Prostatitis / Chronic Pelvic Pain Syndrome (CP/CPPS)
C · InvestigationalInvestigational for category III CP/CPPS: evidence is limited to a 3-patient case report, an uncontrolled Russian series and a comparison in urogenital infection; multimodal therapy remains standard.
Interstitial Cystitis / Bladder Pain Syndrome (Investigational)
C · InvestigationalHighly investigational adjunct for IC/BPS refractory to conventional therapy; no clinical study identified; AUA-guideline stepwise therapy remains primary.
Varicocele (Investigational Adjunct)
C · InvestigationalHighly investigational adjunct in symptomatic varicocele; no varicocele-specific clinical study identified; embolization or surgical ligation remain primary for fertility or pain indications.
Chronic Epididymitis (Investigational Adjunct)
C · InvestigationalInvestigational adjunct for chronic epididymitis after infection ruled out; NSAIDs, scrotal support, and selective surgery (epididymectomy) for refractory cases.
Chronic Orchialgia (Investigational Adjunct)
C · InvestigationalInvestigational adjunct for chronic orchialgia (testicular pain) after workup; pharmacotherapy, pelvic-floor physical therapy, and (selectively) microsurgical denervation of the spermatic cord remain evidence-based.
Prostatic Calculi (Investigational Adjunct)
C · InvestigationalInvestigational adjunct for symptomatic prostatic calculi associated with chronic prostatitis; targeted antibiotics, alpha blockers, and selective transurethral resection remain evidence-based.
Benign Prostatic Hyperplasia (Investigational Adjunct)
C · InvestigationalInvestigational adjunct for symptomatic benign prostatic hyperplasia; alpha-blockers, 5-alpha-reductase inhibitors, and minimally invasive surgical therapy remain evidence-based.
Chronic Pelvic Floor Myalgia (Investigational Adjunct)
C · InvestigationalInvestigational adjunct for chronic pelvic floor myalgia; pelvic-floor physical therapy is first-line; biofeedback, trigger-point injection, and (for selected refractory cases) onabotulinumtoxinA remain evidence-based.
vascular
15 conditions
Chronic Venous Insufficiency (CEAP C3-C5)
B · RCT-supportedOff-label adjunct to compression; the journal evidence is one small open-label randomized trial in varicose veins (n=50) and a 20-patient uncontrolled series; the books describe further reports (see “What the books describe” below).
Venous Leg Ulcer
B · RCT-supportedOff-label adjunct to compression therapy; the journal evidence is one 20-patient uncontrolled series in complicated varicose veins plus case reports; the books add an older report on trophic ulcers of unspecified origin (see “What the books describe” below).
Post-Thrombotic Syndrome
C · InvestigationalInvestigational use; no controlled trial was identified, and the only clinical report is a 1998 conference series of 87 patients without a comparison group.
Varicose Veins (Symptomatic Tributaries)
C · InvestigationalInvestigational use for symptomatic relief of varicose tributary discomfort and inflammation; does not eliminate underlying venous reflux.
Raynaud's Syndrome (Primary)
C · InvestigationalInvestigational use for primary Raynaud's phenomenon; the only clinical report is three patients in a 2025 Azerbaijani case series, with no controlled trial.
Primary or Secondary Lymphedema
C · InvestigationalInvestigational adjunctive use; no clinical study of leech therapy for lymphedema was identified.
Deep Vein Thrombosis (Post-Acute Phase Symptoms)
C · InvestigationalInvestigational use for residual symptoms in the post-acute phase of DVT (>6 weeks); contraindicated in acute DVT.
Superficial Thrombophlebitis (Saphenous Tributary)
C · InvestigationalInvestigational use for superficial thrombophlebitis of saphenous tributaries (not DVT); evidence limited to small, mostly Soviet and Russian series.
Erythromelalgia (Investigational)
C · InvestigationalHighly investigational use for primary or secondary erythromelalgia (red, hot, painful extremities); no clinical study of leech therapy was identified.
Type 2 Diabetes Microvascular Complications (Investigational)
C · InvestigationalInvestigational adjunct for microvascular complications of type 2 diabetes; one small randomized trial in neuropathy plus case reports; glycemic control and standard pharmacotherapy remain primary.
Buerger's Disease / Thromboangiitis Obliterans (Investigational Adjunct)
C · InvestigationalInvestigational adjunct for Buerger's disease; absolute tobacco cessation is the only disease-modifying intervention; iloprost and surgical sympathectomy for selected cases.
Asymptomatic Mild-to-Moderate Carotid Stenosis (Investigational Adjunct)
C · InvestigationalInvestigational adjunct for asymptomatic mild-to-moderate carotid stenosis; risk-factor management (statin, antiplatelet, blood pressure, smoking cessation, glycemic control) remains evidence-based; symptomatic or high-grade disease requires vascular surgery referral.
Hand-Arm Vibration Syndrome (Investigational Adjunct)
C · InvestigationalInvestigational adjunct for vascular and neurosensory components of hand-arm vibration syndrome; cessation of vibration exposure, smoking cessation, calcium channel blockers for vascular component, and gabapentinoids for neurosensory pain remain evidence-based.
Early-Stage Lipedema (Investigational Adjunct)
C · InvestigationalInvestigational adjunct for stage 1 lipedema; no clinical study of leech therapy was identified, and conservative decongestive care remains primary.
Livedoid Vasculopathy (Investigational Adjunct)
C · InvestigationalInvestigational adjunct for livedoid vasculopathy; no clinical leech study was identified, and anticoagulation and IVIG remain guideline first-line.